Growth hormone and the risk of malignancy. [Pediatr Blood Cancer. 2004]

Search for

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Pediatr Blood Cancer. 2004 Oct;43(5):534-5. Links

Growth hormone and the risk of malignancy.

Alter BP.

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Rockville, Maryland, USA. alterb@mail.nih.gov

PMID: 15382267 [PubMed - indexed for MEDLINE]

Controversy about treatment of growth hormone-deficient adults: a commentary. [Ann Intern Med. 2002]
Growth hormone therapy and malignancy. [Horm Res. 1997]
Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults. [Lancet. 1999]
[Growth hormone therapy is useful even for adults] [Duodecim. 1998]
Growth hormone treatment and leukemia. Canadian Growth Hormone Advisory Committee. [Can Dis Wkly Rep. 1988]
» See all Related Articles...

Display Show

Growth hormone and the risk of malignancy.

Related Articles